206 related articles for article (PubMed ID: 35411948)
1. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
[TBL] [Abstract][Full Text] [Related]
2. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
3. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
4. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
[TBL] [Abstract][Full Text] [Related]
5. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
Pavel M; Park SJ; Tanasa R; Rubinsztein DC
Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
[TBL] [Abstract][Full Text] [Related]
6. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.
Romero-Pérez L; Garcia-Sanz P; Mota A; Leskelä S; Hergueta-Redondo M; Díaz-Martín J; López-García MA; Castilla MA; Martínez-Ramírez A; Soslow RA; Matias-Guiu X; Moreno-Bueno G; Palacios J
Mod Pathol; 2015 Nov; 28(11):1492-503. PubMed ID: 26381823
[TBL] [Abstract][Full Text] [Related]
7. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
8. TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
[TBL] [Abstract][Full Text] [Related]
9. Uncovering the relationship between YAP/ WWTR1 (TAZ) genes expression and LncRNAs of SNHG15, HCP5 and LINC01433 in breast cancer tissues.
Beyrami M; Khodadadi I; Tavilani H; Razavi ANE; Karimi J
Pathol Res Pract; 2024 May; 257():155286. PubMed ID: 38599044
[TBL] [Abstract][Full Text] [Related]
10. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
[TBL] [Abstract][Full Text] [Related]
11. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
12. TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
Gershoni A; Hassin O; Nataraj NB; Baruch S; Avioz-Seligman A; Pirona AC; Fellus-Alyagor L; Meir Salame T; Mukherjee S; Mallel G; Yarden Y; Aylon Y; Oren M
Mol Oncol; 2023 Dec; 17(12):2675-2693. PubMed ID: 37716913
[TBL] [Abstract][Full Text] [Related]
13. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.
Soyama H; Nishio M; Otani J; Sakuma T; Takao S; Hara S; Masuda T; Mimori K; Toyokuni S; Lydon JP; Nakao K; Nishina H; Fukumoto T; Maehama T; Suzuki A
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2123134119. PubMed ID: 35858357
[TBL] [Abstract][Full Text] [Related]
14. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
Huang J; Yang J; Zhang Y; Lu D; Dai Y
Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
[TBL] [Abstract][Full Text] [Related]
16. The Hippo pathway effector Wwtr1 regulates cardiac wall maturation in zebrafish.
Lai JKH; Collins MM; Uribe V; Jiménez-Amilburu V; Günther S; Maischein HM; Stainier DYR
Development; 2018 May; 145(10):. PubMed ID: 29773645
[TBL] [Abstract][Full Text] [Related]
17. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein.
Tanas MR; Ma S; Jadaan FO; Ng CK; Weigelt B; Reis-Filho JS; Rubin BP
Oncogene; 2016 Feb; 35(7):929-38. PubMed ID: 25961935
[TBL] [Abstract][Full Text] [Related]
19. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
[TBL] [Abstract][Full Text] [Related]
20. Increased
Park SJ; Frake RA; Rubinsztein DC
Autophagy; 2023 Mar; 19(3):943-944. PubMed ID: 35822241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
